Cargando…

Integrating bioinformatic analysis and detailed experiments reveal an EMT‐related biomarker for clear cell renal cell carcinoma

BACKGROUND: Epithelial–mesenchymal transition (EMT) is associated with early recurrence and a poor prognosis in clear cell renal cell carcinoma (ccRCC). Studies have shown that EMT‐related genes play an important regulatory role in tumor invasion, metastasis, and drug resistance, but the biological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Yue, Ma, Sheng, Zhang, Junbiao, Xiong, Zezhong, Li, Beining, Ma, Siquan, Liu, Bo, Yao, Xiangyang, Wang, Zhihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557903/ https://www.ncbi.nlm.nih.gov/pubmed/37676078 http://dx.doi.org/10.1002/cam4.6504

Ejemplares similares

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma
por: Ma, Sheng, et al.
Publicado: (2023)

Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis
por: Zhang, Ning, et al.
Publicado: (2020)

Bioinformatics analysis reveals biomarkers with cancer stem cell characteristics in kidney renal clear cell carcinoma
por: Zhang, Zan, et al.
Publicado: (2021)

Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining
por: Xu, Zekun, et al.
Publicado: (2023)

Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics
por: Li, Le, et al.
Publicado: (2023)

TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT
por: Zhong, Mengya, et al.
Publicado: (2020)

Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model
por: Liu, Bin, et al.
Publicado: (2020)

Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy
por: Xiang, Zhenfei, et al.
Publicado: (2021)

Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma
por: Meng, Meng, et al.
Publicado: (2021)

Targeting Alpha‐Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD‐1 Blockade Immunotherapy in Renal Cell Carcinoma
por: Li, Le, et al.
Publicado: (2023)

PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis
por: Luo, Yongwen, et al.
Publicado: (2019)

DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
por: Lee, Man-Gang, et al.
Publicado: (2022)

Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis
por: Zhou, Libin, et al.
Publicado: (2019)

Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma
por: Wu, Zonglong, et al.
Publicado: (2022)

Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis
por: Peng, Longfei, et al.
Publicado: (2022)

Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma
por: Pan, Ziwen, et al.
Publicado: (2022)

Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma
por: Wu, Yunfei, et al.
Publicado: (2023)

Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology
por: Meng, Zhuo, et al.
Publicado: (2023)

Construction of EMT related prognostic signature for kidney renal clear cell carcinoma, through integrating bulk and single-cell gene expression profiles
por: Huang, Qi, et al.
Publicado: (2023)

Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma
por: Zhang, Xiaoqin, et al.
Publicado: (2021)

Comprehensive bioinformatics analyses of APOBECs family and identification of APOBEC3D as the unfavorable prognostic biomarker in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2021)

Identification TRIM46 as a Potential Biomarker and Therapeutic Target for Clear Cell Renal Cell Carcinoma Through Comprehensive Bioinformatics Analyses
por: Ren, Xiang-bin, et al.
Publicado: (2021)

Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC)
por: Quan, Jing, et al.
Publicado: (2021)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma
por: Luo, Ting, et al.
Publicado: (2018)

Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma
por: Wang, Jinxing, et al.
Publicado: (2018)

Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
por: Huang, Hao, et al.
Publicado: (2021)

The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high‐throughput data
por: Zhang, Bo, et al.
Publicado: (2019)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma
por: Li, Weiquan, et al.
Publicado: (2022)

FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis
por: Huang, Xing, et al.
Publicado: (2022)

Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis
por: Wang, Qian, et al.
Publicado: (2019)

C chemokines are prognostic biomarkers correlated with diverse immune cell infiltrations in clear cell renal cell carcinoma
por: Chen, Zhiguo, et al.
Publicado: (2022)

Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma
por: Chao, Xiaoyu, et al.
Publicado: (2021)

Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-κB and JNK dependent manner
por: An, Jiabin, et al.
Publicado: (2015)

ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway
por: Xu, Jinming, et al.
Publicado: (2023)

NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
por: Chen, Jiasheng, et al.
Publicado: (2022)

ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma
por: Shao, Yuan, et al.
Publicado: (2023)

Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach
por: Chen, Yongsheng, et al.
Publicado: (2016)

Identification of significant genes with prognostic influence in clear cell renal cell carcinoma via bioinformatics analysis
por: Zhang, Fangyuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v8m9hgn30oc1uvgt78cdgf0oli